Patients often notice changes well beyond appetite when starting GLP-1 medications such as semaglutide or tirzepatide
For example, beneficial bacteria such as bifidobacteria are decreased in patients with chronic pancreatitis or recurrent acute pancreatitis.[ref] Animal studies show that there is a significant decrease in gut microbial diversity in pancreatitis
Palazzese L., Gosalvez, J., Anzalone, D.A., Loi, P
Your care team should also look at overall health, goals and insurance criteria
Editorial Advisory Board Member, Harvard Health Publishing Semaglutide (Ozempic, Wegovy), a GLP-1 agonist drug used to treat diabetes and obesity, may also help people with fatty liver disease, called metabolic dysfunctionassociated steatotic liver disease (MASLD)
Some people feel a gentle dimming of hunger within days